BCL2A1 and neoplasm: We found that knockout of BCL2A1 in ES-2 (BCL2A1−/− ES-2) cells significantly reduced tumor nodule formation (Figure 7F–H) and improved the survival rate of SCID mice that were i.p. injected with ES-2 scrambled control cells (Figure 7I).